Tevogen Bio believes that its investigational highly purified antigen-specific T cell therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A. This collaboration aims to harness Tevogen's proprietary immunotherapy platform and Dr. Flomenberg's expertise in immunology, histocompatibility and pioneering work in the immunology of stem cell transplantation.
Read MoreTevogen Bio believes that its highly purified antigen specific T cell investigational therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A
Read MoreThe Office of Public Health is holding a special, no cost to the patient vaccination day on Thursday, Dec. 13, 2018, from 2 p.m. to 6:30 p.m., and CARE, Inc., encourages all employees, clients, and their families to take advantage.
Read MoreTowel Tech's groundbreaking new gym towel calls on breakthrough fiber technology to resist bacteria and microbes, while at the same time exceeding the functionality of most existing fitness towel products. From its sleek zippered mesh pocket and color-coded sides to a powerful small magnet that allows it to attach to the side of equipment rather than lie on the floor - Towel Tech is a game-changer set to help thousands avoid contracting colds and the flu from their local health club.
Read MoreEnigma Diagnostics Ltd, a spin-out company of Ploughshare Innovations, has successfully completed its analytical and diagnostic verification of its FluAB-RSV diagnostic assay on the Enigma® ML system, which looks set to benefit many flu sufferers
Read MoreViennese biotech company's smart respiratory technology already authorized in 38 countries
An innovative nasal spray that has been proven clinically effective against respiratory viruses has now been authorized for the Canad
Georgia-Pacific Professional and its enMotion® brand of touchless dispensers today received the Best Marketing Innovation of the Decade Award, presented by Georgia State University's Robinson College of Business and the Atlanta Business Chronicle.
Read More